USP9X and cancer: Indeed, structure based mutations of USP9X which disrupt zinc-binding alter its activity towards specific types of ubiquitin chain linkages23, while the presence of multiple deleterious cancer variants (p.Asp1761Tyr, p.Asp1720Asn and p.Arg1783Cys) in the zinc finger motif provide additional support of its importance.